Corbus Pharmaceuticals Holdings Inc Surges on Promising Drug Candidate CRB701
On January 27, 2024, Corbus Pharmaceuticals Holdings, Inc. made an exciting revelation about its drug candidate CRB-701, leading to a...
On January 27, 2024, Corbus Pharmaceuticals Holdings, Inc. made an exciting revelation about its drug candidate CRB-701, leading to a...
As of January 27, 2024, there has been notable insider activity at Minerals Technologies (NYSE: MTX). Key executives, including Michael...
As of January 27, 2024, no substantial details have been found regarding RBC Capital's reaffirmation of Fair Isaac. Their stance...
On January 27, 2024, Christopher Allen, an analyst at Citigroup, expressed his optimism for Virtu Financial (NASDAQ: VIRT) by reiterating...
On January 27, 2024, Andrew Kaplowitz, a renowned analyst at Citigroup, expressed his unwavering confidence in Quanta Services (NYSE:PWR) by...
On January 27, 2024, Itay Michaeli, an analyst at Citigroup, expressed a cautious stance towards Tesla (NASDAQ:TSLA) by maintaining a...
On January 27, 2024, groundbreaking news emerged in the field of urothelial carcinoma treatment. Merck's revolutionary drug, KEYTRUDA (pembrolizumab), has...
On January 27, 2024, Goldman Sachs analyst Jerry Revich expressed his optimism for United Rentals (NYSE: URI) by maintaining a...
On January 27, 2024, Bruno Amorim, an analyst from Goldman Sachs, expressed his positive stance on Controladora Vuela (NYSE:VLRS) by...
The recent options activity surrounding ASML Holding (NASDAQ: ASML) has caught the attention of astute investors. A thorough analysis of...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com